RECURRENT NON-SMALL CELL LUNG CARCINOMA
Clinical trials for RECURRENT NON-SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NON-SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT NON-SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo shows promise in Tough-to-Treat lung cancer
Disease control CompletedThis study tested a new combination treatment for people with advanced non-small cell lung cancer that had already been treated. The treatment combined a cancer vaccine (TG4010) with an immunotherapy drug (nivolumab) to help the immune system fight the cancer. The trial included …
Matched conditions: RECURRENT NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated May 26, 2026 11:38 UTC
-
Promising combo targets tough cancers in early trial
Disease control CompletedThis study tested a combination of two drugs—sEphB4-HSA and pembrolizumab—in 42 people with advanced non-small cell lung cancer or head & neck cancer that had spread or returned. The goal was to see if the combo could shrink tumors better than standard treatments. Participants ha…
Matched conditions: RECURRENT NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 26, 2026 11:30 UTC
-
New combo therapy tested for common lung cancer mutation
Disease control CompletedThis study tested whether adding cetuximab to afatinib helps people with advanced EGFR-mutant non-small cell lung cancer live longer compared to afatinib alone. It included 174 newly diagnosed or recurrent patients. The goal was to see if the combination improves survival and del…
Matched conditions: RECURRENT NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 26, 2026 11:26 UTC
-
New drug cocktail shows promise for tough lung cancers
Disease control CompletedThis study tested two drugs, auranofin and sirolimus, together in 29 people with advanced lung cancer that had stopped responding to standard treatments. The goal was to find the best dose and see if the combination could slow or stop cancer growth. The trial focused on safety an…
Matched conditions: RECURRENT NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 11:24 UTC
-
Could a diabetes drug boost lung cancer treatment?
Disease control CompletedThis study looked at whether adding metformin (a common diabetes medicine) to standard chemotherapy and radiation helps people with stage III non-small cell lung cancer live longer without their cancer growing. About 170 adults with this type of lung cancer took part. The goal wa…
Matched conditions: RECURRENT NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Focused radiation beams take aim at multiple tumors in early trial
Symptom relief CompletedThis early-stage study tested a precise, high-dose radiation technique called stereotactic body radiotherapy (SBRT) in 42 people with breast, lung, or prostate cancer that had spread to several places in the body. The main goal was to find the safest dose and check for side effec…
Matched conditions: RECURRENT NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 26, 2026 11:36 UTC